Making earlier cancer detection a routine part of medical care

Cologuard is having a meaningful impact and powering leadership in colorectal cancer screening 10M people screened 315K precancerous cases detected 300K providers ordered 46K early-stage cancers detected 56.0 20.9 1999 Source: based on extrapolation of findings in DeeP-C pivotal trial population to the nearly 10M people screened with Cologuard since launch; Imperiale TF et al., N Engl J Med (2014); Centers for Disease Control and Prevention EXACT SCIENCES Rate of new cases Rate of deaths Colorectal cancer rates per 100,000 people 2004 2009 2014 36.3 12.8 2019 € 8

View entire presentation